Novy, Emmanuel http://orcid.org/0000-0002-0282-8106
Rivière, Jérémie
Nguyen, Maxime
Arfeuille, Gaëlle
Louis, Guillaume
Bouhemad, Bélaïd
Pottecher, Julien
Hecketsweiler, Stéphane
Germain, Adeline
Laithier, François-Xavier
Losser, Marie-Reine
Debourgogne, Anne
Bernard, Yohann
Rousseau, Hélène
Baumann, Cédric
Luc, Amandine
Birckener, Julien
Machouart, Marie-Claire
Guerci, Philippe
Funding for this research was provided by:
MSD
Article History
Received: 10 October 2023
Accepted: 28 November 2023
First Online: 30 November 2023
Declarations
:
: The pBDG2 study was classified as noninterventional. Consequently, the need for informed consent was waived, and patients or substitute decision-makers were only asked if they declined to participate. The study was conducted according to the guidelines of the Declaration of Helsinki and was approved by the local ethics committee of Nancy, France (N°334). All personal and medical information is being collected and shared in accordance with medical confidentiality as well as French and European regulations regarding data protection. Furthermore, all data are being recorded in a secured database for statistical analysis with deidentification (number of the center, first letter of name and last name).The study was registered with ClinicalTrials.gov (ID number 03997929, first registered on June 24, 2019).
: Not applicable.
: The authors have disclosed that they do not have any conflicts of interest.